GO:0070012 oligopeptidase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070012 oligopeptidase activity describes the catalysis of peptide bond hydrolysis in oligopeptides, molecules containing 2 to 20 amino acid residues connected by peptide bonds.
• Oligopeptidases such as Ndel1 and prolyl oligopeptidase (PREP) regulate neuropeptide processing and are implicated in schizophrenia and congenital Zika syndrome [1,2,4,6].
• Ndel1 oligopeptidase activity is reduced in early-stage schizophrenia and is inhibited by DISC1, linking the activity to disease mechanisms [1,4].
• Prolyl oligopeptidase (PREP) adopts a serine protease fold with a unique beta-propeller domain that controls substrate access.
• Bacterial oligopeptidases, including acylpeptidyl oligopeptidase in Porphyromonas gingivalis and a prolyl oligopeptidase in Mycobacterium tuberculosis, contribute to growth and virulence [3,5].
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of oligopeptidase genes in disease and microbial contexts.
Description
Oligopeptidase activity (GO:0070012) is a molecular function defined as the catalysis of peptide bond hydrolysis in an oligopeptide, a molecule containing a small number (2 to 20) of amino acid residues connected by peptide bonds. This activity is central to the processing and turnover of short peptides, including neuropeptides and bacterial signaling peptides, and is carried out by a diverse set of enzymes that often combine a catalytic protease domain with regulatory modules. Because oligopeptidases act on short substrates rather than large proteins, they occupy a distinct functional niche relative to endoproteases and exopeptidases, and their dysregulation has been linked to neuropsychiatric and infectious disease states [1,2,6]. Researchers study oligopeptidase activity to understand how short peptide signals are generated and terminated in the brain, how bacterial pathogens process peptides for growth and virulence, and how mutations or inhibitors alter these processes [3,4,5]. The activity is experimentally tractable: purified enzymes can be assayed with fluorogenic oligopeptide substrates, and cellular models can be engineered to test the consequences of loss or gain of function [1,2,8]. As a result, GO:0070012 sits at the intersection of neurobiology, microbiology, and drug discovery, and it is increasingly targeted in CRISPR-based functional studies. This article summarizes the authoritative definition, the major genes and proteins associated with oligopeptidase activity, the mechanistic and structural features that define the function, and the experimental methods used to study it. All statements are grounded in the verified literature cited by number.
oligopeptidase activity At A Glance
| GO ID | GO:0070012 |
|---|---|
| GO term | oligopeptidase activity |
| Ontology | molecular_function |
| Synonym | none |
| Definition | Catalysis of the hydrolysis of a peptide bond in an oligopeptide, i.e. a molecule containing a small number (2 to 20) of amino acid residues connected by peptide bonds. |
| Substrate range | Oligopeptides of 2 to 20 amino acid residues |
| Representative enzymes | Ndel1, prolyl oligopeptidase (PREP), acylpeptidyl oligopeptidase, M. tuberculosis puromycin hydrolase |
| Disease links | Schizophrenia, congenital Zika syndrome, bacterial virulence |
| Research methods | Fluorogenic peptide assays, CRISPR knockout, point mutation, knock-in, overexpression |
What Is GO:0070012?
In simple terms, oligopeptidase activity means cutting short peptides. More precisely, GO:0070012 describes the catalysis of the hydrolysis of a peptide bond in an oligopeptide, where an oligopeptide is a molecule containing a small number (2 to 20) of amino acid residues connected by peptide bonds. This activity is classified under the molecular_function aspect of the Gene Ontology and is distinct from activities that act on full-length proteins or on single amino acids.
Why Is oligopeptidase activity Important in Cell Biology?
Oligopeptidase activity is important because it controls the lifetime and abundance of short peptides that act as signaling molecules, and because its dysregulation is associated with major human diseases. In the brain, Ndel1 oligopeptidase activity is reduced in early-stage schizophrenia and is inhibited by DISC1, suggesting a direct mechanistic link between this activity and neuropsychiatric disease [1,4]. In congenital Zika syndrome, Ndel1 oligopeptidase activity has been proposed as a predictor of endophenotype and treatment response. In bacteria, oligopeptidases such as acylpeptidyl oligopeptidase in Porphyromonas gingivalis and a prolyl oligopeptidase in Mycobacterium tuberculosis contribute to growth, virulence, and drug metabolism, making them potential antimicrobial targets [3,5]. Understanding GO:0070012 therefore informs neurobiology, infectious disease, and therapeutic development.
• Regulates neuropeptide processing and signaling in the central nervous system.
• Ndel1 oligopeptidase activity is a potential biomarker of early-stage schizophrenia.
• DISC1 inhibits NUDEL (Ndel1) oligopeptidase activity, linking genetic risk to enzyme function.
• Ndel1 oligopeptidase activity may predict congenital Zika syndrome endophenotype and treatment response.
• Prolyl oligopeptidase (PREP) structure and dynamics are targets for CNS drug development.
• Bacterial acylpeptidyl oligopeptidase contributes to Porphyromonas gingivalis growth and gingipain activity.
• Mycobacterium tuberculosis puromycin hydrolase displays a prolyl oligopeptidase fold and acyl aminopeptidase activity.
• Thermostable S9 prolyl oligopeptidases have biotechnological applications.
• Oligopeptidases are tractable targets for CRISPR-based functional genomics.
• Assays for oligopeptidase activity support biomarker and drug discovery studies [1,2].
Molecular Mechanism of oligopeptidase activity
Substrate recognition and binding
In simple terms: The enzyme first grabs a short peptide.
Oligopeptidases recognize oligopeptides of 2 to 20 residues. Prolyl oligopeptidase (PREP) uses a beta-propeller domain to filter substrate access, allowing only short peptides to reach the catalytic site. This structural feature distinguishes oligopeptidases from broad-specificity proteases and underlies their selectivity for short substrates.
Catalytic mechanism
In simple terms: The enzyme cuts the peptide bond using a catalytic triad.
Many oligopeptidases, including PREP and the Mycobacterium tuberculosis puromycin hydrolase, adopt a serine protease fold with a catalytic triad that mediates peptide bond hydrolysis [5,7]. The M. tuberculosis enzyme displays a prolyl oligopeptidase fold and an acyl aminopeptidase activity, illustrating mechanistic diversity within GO:0070012. A hyperstable S9 prolyl oligopeptidase from Thermotoga naphthophila also exhibits lipolytic activity, showing that some oligopeptidases have additional catalytic capabilities.
Regulation by protein partners
In simple terms: Other proteins can switch the enzyme on or off.
Ndel1 oligopeptidase activity is inhibited by disrupted-in-schizophrenia 1 (DISC1), providing a direct example of regulation by a protein partner. This interaction links a genetic risk factor for schizophrenia to the enzymatic activity of Ndel1. In Porphyromonas gingivalis, a GntR family transcription factor regulates bacterial growth, acylpeptidyl oligopeptidase, and gingipain activity, indicating transcriptional control of oligopeptidase expression.
Roles in neuropeptide processing
In simple terms: In the brain, these enzymes help control peptide signals.
Neuropeptides and oligopeptidases are functionally linked in schizophrenia, where altered peptide processing may contribute to disease pathophysiology. Ndel1 oligopeptidase activity is reduced in early stages of schizophrenia, supporting a role for this activity in neuropeptide metabolism. In congenital Zika syndrome, Ndel1 oligopeptidase activity has been assessed as a potential predictor of endophenotype and treatment response.
Bacterial and biotechnological functions
In simple terms: Bacteria use these enzymes too, and some are useful in industry.
Acylpeptidyl oligopeptidase in Porphyromonas gingivalis is regulated by a GntR family transcription factor and contributes to bacterial growth and gingipain activity. The Mycobacterium tuberculosis puromycin hydrolase, which has a prolyl oligopeptidase fold, may contribute to drug metabolism. A hyperstable S9 prolyl oligopeptidase from Thermotoga naphthophila has applications in biotechnology due to its stability and lipolytic activity.
Key Genes Involved in GO:0070012 oligopeptidase activity
The following genes and proteins are experimentally linked to oligopeptidase activity (GO:0070012) in the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NDEL1 | Encodes Ndel1, an oligopeptidase that processes neuropeptides | Biomarker of early-stage schizophrenia; inhibited by DISC1 [1,4] |
| DISC1 | Inhibits NUDEL (Ndel1) oligopeptidase activity | Genetic risk factor for schizophrenia; regulator of oligopeptidase function |
| PREP | Prolyl oligopeptidase with a beta-propeller domain | CNS drug target; structure and dynamics studied |
| PGN_1296 | GntR family transcription factor regulating acylpeptidyl oligopeptidase | Regulates Porphyromonas gingivalis growth and gingipain activity |
| PGN_1295 | Acylpeptidyl oligopeptidase in Porphyromonas gingivalis | Contributes to bacterial growth and virulence |
| Rv3634c | Mycobacterium tuberculosis puromycin hydrolase with prolyl oligopeptidase fold | Potential drug target; acyl aminopeptidase activity |
| Tnap_0755 | Hyperstable S9 prolyl oligopeptidase from Thermotoga naphthophila | Biotechnological applications; lipolytic activity |
| NDEL1 (NUDEL) | Oligopeptidase involved in neurodevelopment | Linked to schizophrenia and congenital Zika syndrome [1,2] |
| PREP (POP) | Serine protease with oligopeptidase activity | Target for CNS disorders |
| DISC1 (LOD) | Protein partner that inhibits Ndel1 | Schizophrenia risk gene |
| PGN_1296 (GntR) | Transcriptional regulator | Controls oligopeptidase expression in P. gingivalis |
| Rv3634c (Mtb) | Prolyl oligopeptidase-like enzyme | Mycobacterial drug metabolism |
| Tnap_0755 (Tn) | Thermostable prolyl oligopeptidase | Industrial biocatalysis |
| NDEL1 (mouse) | Murine ortholog of Ndel1 | Model for neuropeptide processing [1,4] |
| PREP (human) | Human prolyl oligopeptidase | Structural and pharmacological studies |
| PGN_1295 (Pg) | Acylpeptidyl oligopeptidase | Periodontal disease research |
| Rv3634c (Mtb) | Puromycin hydrolase | Tuberculosis research |
How Is oligopeptidase activity Regulated?
Oligopeptidase activity is regulated at multiple levels. At the protein level, Ndel1 oligopeptidase activity is inhibited by DISC1, providing a direct physical regulatory mechanism. At the transcriptional level, a GntR family transcription factor regulates acylpeptidyl oligopeptidase expression in Porphyromonas gingivalis, linking bacterial growth and gingipain activity to oligopeptidase levels. In the brain, neuropeptide processing by oligopeptidases is subject to physiological regulation that may be altered in schizophrenia. Additionally, the structural dynamics of prolyl oligopeptidase, including its beta-propeller domain, influence substrate access and catalytic activity.
oligopeptidase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NDEL1 | Schizophrenia | CRISPR knockout or point mutation in neuronal cell lines; patient-derived iPSCs [1,4] |
| NDEL1 | Congenital Zika syndrome | Zika virus infection in neural progenitor cells with NDEL1 knockout |
| PREP | CNS disorders | Knockout or overexpression in neuroblastoma cells; structural studies |
| PGN_1295 | Periodontal disease | Porphyromonas gingivalis knockout and mouse infection models |
| Rv3634c | Tuberculosis | Mycobacterium tuberculosis knockout and macrophage infection models |
Schizophrenia and neuropsychiatric disorders
Ndel1 oligopeptidase activity is reduced in early stages of schizophrenia, suggesting it may serve as a biomarker for early detection. DISC1, a genetic risk factor for schizophrenia, inhibits NUDEL (Ndel1) oligopeptidase activity, providing a molecular link between genetic risk and enzyme dysfunction. Neuropeptides and oligopeptidases are broadly implicated in schizophrenia pathophysiology, supporting the relevance of GO:0070012 to psychiatric disease.
Congenital Zika syndrome
Ndel1 oligopeptidase activity has been assessed as a potential predictor of congenital Zika syndrome endophenotype and treatment response, indicating that this activity may influence neurodevelopmental outcomes following infection.
Bacterial infections and virulence
In Porphyromonas gingivalis, acylpeptidyl oligopeptidase is regulated by a GntR family transcription factor and contributes to bacterial growth and gingipain activity, which are important for periodontal disease pathogenesis. Mycobacterium tuberculosis puromycin hydrolase, which has a prolyl oligopeptidase fold, may play a role in drug metabolism and bacterial survival.
From oligopeptidase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NDEL1 oligopeptidase activity alter neuropeptide processing? | CRISPR knockout of NDEL1 in neuronal cell lines [1,4] |
| Does a specific point mutation in PREP alter substrate specificity? | CRISPR point mutation knock-in in HEK293 or neuroblastoma cells |
| Can tagged Ndel1 be used to monitor oligopeptidase activity in live cells? | Knock-in of fluorescent or affinity tags at the endogenous NDEL1 locus [1,2] |
| Does overexpression of PREP change neuropeptide levels? | Overexpression of PREP in neuronal cells |
| Does acylpeptidyl oligopeptidase contribute to P. gingivalis virulence? | CRISPR knockout of PGN_1295 in P. gingivalis |
| Does the GntR transcription factor regulate oligopeptidase expression? | Knockout or overexpression of PGN_1296 in P. gingivalis |
How to Study the oligopeptidase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorogenic peptide assay | Oligopeptidase catalytic activity | Quantify Ndel1 or PREP activity in cells or clinical samples [1,4] |
| CRISPR knockout | Loss-of-function effects | Test whether a gene is required for oligopeptidase activity [1,3] |
| CRISPR point mutation | Specific residue function | Dissect catalytic triad or substrate-binding residues |
| CRISPR knock-in | Tagged protein localization and interactions | Monitor endogenous oligopeptidase in live cells |
| Overexpression | Gain-of-function effects | Assess excess oligopeptidase activity on peptide processing |
| X-ray crystallography | Three-dimensional structure | Determine active site and domain architecture |
| Molecular dynamics | Protein dynamics and substrate access | Study beta-propeller gating in PREP |
| Bacterial growth assays | Microbial fitness | Evaluate acylpeptidyl oligopeptidase in P. gingivalis |
Enzymatic activity assays
Oligopeptidase activity is commonly measured using fluorogenic oligopeptide substrates that release a fluorescent product upon cleavage. Such assays have been used to quantify Ndel1 oligopeptidase activity in clinical samples and to assess inhibition by DISC1 [1,4]. These assays are adaptable to high-throughput screening for inhibitors or activators [1,2].
CRISPR-based genetic models
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of oligopeptidase genes. For example, knockout of NDEL1 can reveal its role in neuropeptide processing, while point mutations can dissect catalytic residues [1,4]. Knock-in of tags enables localization and interaction studies.
Structural and biophysical methods
X-ray crystallography, NMR, and molecular dynamics simulations have been used to study the structure and dynamics of prolyl oligopeptidase, including its beta-propeller domain. These methods reveal how substrate access and catalytic activity are controlled.
Microbiological and infection models
Bacterial oligopeptidases can be studied using knockout strains and infection models. In Porphyromonas gingivalis, knockout of acylpeptidyl oligopeptidase or its regulator allows assessment of growth and gingipain activity. Mycobacterium tuberculosis puromycin hydrolase can be studied in mycobacterial cultures and macrophage infection models.
How CRISPR Can Be Used to Study GO:0070012 oligopeptidase activity
Knockout
CRISPR knockout of oligopeptidase genes such as NDEL1 or PREP can abolish enzymatic activity and reveal its contribution to neuropeptide processing, cell survival, or bacterial growth [1,3,4]. Knockout models are essential for establishing causality in disease pathways.
Point Mutation
CRISPR point mutation can be used to alter catalytic residues or regulatory sites within oligopeptidase genes, allowing precise structure-function analysis. For example, mutating the catalytic triad of PREP can test its role in substrate hydrolysis.
Knock-in
Knock-in of tags or reporter sequences at endogenous oligopeptidase loci enables real-time monitoring of protein localization and activity. This approach is valuable for studying Ndel1 dynamics in neurons.
Overexpression
CRISPR activation or cDNA overexpression can increase oligopeptidase levels to test gain-of-function effects on peptide processing and disease phenotypes. Overexpression models complement knockout studies by revealing dose-dependent effects.
How EDITGENE Supports oligopeptidase activity Research
Researchers studying oligopeptidase activity-related genes often need to determine whether a candidate gene is causally involved in peptide processing, disease pathogenesis, or drug response. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for oligopeptidase activity research.
Frequently Asked Questions About oligopeptidase activity
What is oligopeptidase activity?
Oligopeptidase activity (GO:0070012) is the catalysis of peptide bond hydrolysis in an oligopeptide, a molecule containing 2 to 20 amino acid residues connected by peptide bonds.
What genes are involved in oligopeptidase activity?
Key genes include NDEL1, DISC1, PREP, and bacterial genes such as PGN_1295 and Rv3634c [1,3,4,5,7].
What diseases are linked to oligopeptidase activity?
Oligopeptidase activity has been linked to schizophrenia, congenital Zika syndrome, and bacterial infections such as periodontal disease and tuberculosis [1,2,3,5].
How is oligopeptidase activity measured?
It is commonly measured using fluorogenic oligopeptide substrates that release a fluorescent signal upon cleavage [1,4].
What is the role of Ndel1 oligopeptidase activity in schizophrenia?
Ndel1 oligopeptidase activity is reduced in early-stage schizophrenia and is inhibited by DISC1, suggesting a role in disease mechanisms [1,4].
What is prolyl oligopeptidase (PREP)?
PREP is a serine protease with a beta-propeller domain that restricts substrate access and is a target for CNS drug development.
Can CRISPR be used to study oligopeptidase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to study oligopeptidase genes and their functions [1,2,3,7].
What is the substrate range of oligopeptidases?
Oligopeptidases act on oligopeptides containing 2 to 20 amino acid residues connected by peptide bonds.
Are there bacterial oligopeptidases?
Yes, examples include acylpeptidyl oligopeptidase in Porphyromonas gingivalis and a prolyl oligopeptidase in Mycobacterium tuberculosis [3,5].
What is the GO ID for oligopeptidase activity?
The GO ID is GO:0070012, classified under molecular_function.
Conclusion
Oligopeptidase activity (GO:0070012) is a distinct molecular function that governs the hydrolysis of short peptides and is implicated in neuropsychiatric disorders, congenital infections, and bacterial virulence [1,2,3,4,5,6]. The activity is carried out by structurally diverse enzymes, including Ndel1 and prolyl oligopeptidase, whose mechanisms and regulation are increasingly well understood [4,7]. CRISPR-based models provide a powerful approach to test the causal roles of these enzymes in disease and to identify new therapeutic targets.
References
- 1. Dal Mas C et al.. 2019. Ndel1 oligopeptidase activity as a potential biomarker of early stages of schizophrenia.. Schizophr Res 208:202-208 PMID: 30857875
- 2. Christoff RR et al.. 2023. Assessing the role of Ndel1 oligopeptidase activity in congenital Zika syndrome: Potential predictor of congenital syndrome endophenotype and treatment response.. J Neurochem 166(4):763-776 PMID: 37497817
- 3. Qiu Y et al.. 2023. A GntR family transcription factor in Porphyromonas gingivalis regulates bacterial growth, acylpeptidyl oligopeptidase, and gingipains activity.. Mol Oral Microbiol 38(1):48-57 PMID: 36349810
- 4. Hayashi MA et al.. 2005. Inhibition of NUDEL (nuclear distribution element-like)-oligopeptidase activity by disrupted-in-schizophrenia 1.. Proc Natl Acad Sci U S A 102(10):3828-33 PMID: 15728732
- 5. Zhao Y et al.. 2021. Mycobacterium tuberculosis puromycin hydrolase displays a prolyl oligopeptidase fold and an acyl aminopeptidase activity.. Proteins 89(6):614-622 PMID: 33426726
- 6. Rodríguez B et al.. 2020. Neuropeptides and oligopeptidases in schizophrenia.. Neurosci Biobehav Rev 108:679-693 PMID: 31794779
- 7. Rea D et al.. 2011. Prolyl oligopeptidase structure and dynamics.. CNS Neurol Disord Drug Targets 10(3):306-10 PMID: 21222626
- 8. Akram F et al.. 2024. Gene cloning, IPTG-independent auto-induction and characterization of a novel hyperstable S9 prolyl oligopeptidase having lipolytic activity from Thermotoga naphthophila RKU-10(T) with applications.. Int J Biol Macromol 279(Pt 1):135107 PMID: 39197610
